Hallucinogen persisting perception disorder

Hallucinogen persisting perception disorder
HPPD noise simulation, often referred to as visual snow
SpecialtyPsychiatry

Hallucinogen persisting perception disorder (HPPD) is a non-psychotic disorder in which a person experiences apparent lasting or persistent visual hallucinations or perceptual distortions after using drugs,[1] including but not limited to psychedelics, dissociatives, entactogens, tetrahydrocannabinol (THC), and SSRIs.[2][3] Despite being designated as a hallucinogen-specific disorder, the specific contributory role of psychedelic drugs is unknown.

The hallucinations and perceptual changes consist of, but are not limited to, visual snow, trails and after images (palinopsia), light fractals on flat surfaces, intensified colors, altered motion perception, pareidolia, micropsia, and macropsia.[3] People who have never previously taken drugs have also reported some symptoms associated with HPPD (such as floaters and visual snow).[4][5]

HPPD is a DSM-5 diagnosis with diagnostic code 292.89 (F16.983).[6] For the diagnosis to be made, other psychological, psychiatric, or neurological conditions must be ruled out and it must cause distress in everyday life.[6] In the ICD-10, the diagnosis code F16.7 corresponds most closely to the clinical picture. HPPD is rarely recognized amongst both hallucinogen users and psychiatrists, and is often misdiagnosed as a substance-induced psychosis.

Newer research makes a distinction between HPPD I and HPPD II.[3] The more drastic cases, as seen in HPPD II, are believed to be caused by the use of psychedelics as well as comorbid mental disorders.[3] Some people who have this disorder report that they developed symptoms of HPPD after their first use of such drugs (most notably LSD). Because research regarding HPPD is currently lacking, there is little information on effective treatments, its aetiology and relationship to other disorders, and precise mechanism.[7]

  1. ^ Vis PJ, Goudriaan AE, Ter Meulen BC, Blom JD (2021). "On Perception and Consciousness in HPPD: A Systematic Review". Frontiers in Neuroscience. 15: 675768. doi:10.3389/fnins.2021.675768. PMC 8385145. PMID 34456666.
  2. ^ "New Study: Antidepressants, Vision Problems, & VSS!". 20 March 2022.
  3. ^ a b c d Martinotti G, Santacroce R, Pettorruso M, Montemitro C, Spano MC, Lorusso M, et al. (March 2018). "Hallucinogen Persisting Perception Disorder: Etiology, Clinical Features, and Therapeutic Perspectives". Brain Sciences. 8 (3): 47. doi:10.3390/brainsci8030047. PMC 5870365. PMID 29547576.
  4. ^ Zobor D, Strasser T, Zobor G, Schober F, Messias A, Strauss O, et al. (April 2015). "Ophthalmological assessment of cannabis-induced persisting perception disorder: is there a direct retinal effect?". Documenta Ophthalmologica. Advances in Ophthalmology. 130 (2): 121–130. doi:10.1007/s10633-015-9481-2. PMID 25612939. S2CID 9684212.
  5. ^ Krebs TS, Johansen PØ (19 August 2013). "Psychedelics and mental health: a population study". PLOS ONE. 8 (8): e63972. Bibcode:2013PLoSO...863972K. doi:10.1371/journal.pone.0063972. PMC 3747247. PMID 23976938.
  6. ^ a b Cite error: The named reference Halpern_2016 was invoked but never defined (see the help page).
  7. ^ Halpern JH, Pope HG (March 2003). "Hallucinogen persisting perception disorder: what do we know after 50 years?". Drug and Alcohol Dependence. 69 (2): 109–119. doi:10.1016/s0376-8716(02)00306-x. PMID 12609692.

© MMXXIII Rich X Search. We shall prevail. All rights reserved. Rich X Search